REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro De Terapia Integral Melius Ips S.A.S (Colombia)

Main Activities: Other Ambulatory Health Care Services
Secondary Activities: Educational Support Services | Diagnostic Imaging Centers
Full name: Centro De Terapia Integral Melius Ips S.A.S Profile Updated: January 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Centro De Terapia Integral Melius Ips S.A.S is based in Colombia, with the head office in Valledupar. The enterprise operates in the Other Ambulatory Health Care Services industry. Centro De Terapia Integral Melius Ips S.A.S was incorporated on October 07, 2022. There was a net sales revenue increase of 34.37% reported in Centro De Terapia Integral Melius Ips S.A.S’s latest financial highlights for 2025. During that time, Centro De Terapia Integral Melius Ips S.A.S’s total assets decreased by 74.02%. Centro De Terapia Integral Melius Ips S.A.S’s net profit margin increased by 30.35% in 2025.

Headquarters
Cr 19 2 D 12Lc 01
Valledupar; Cesar;

Contact Details: Purchase the Centro De Terapia Integral Melius Ips S.A.S report to view the information.

Basic Information
Registered Capital:
Purchase the Centro De Terapia Integral Melius Ips S.A.S report to view the information.
Financial Auditors:
Purchase the Centro De Terapia Integral Melius Ips S.A.S report to view the information.
Incorporation Date:
October 07, 2022
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro De Terapia Integral Melius Ips S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
34.37%
Total Operating Revenue
34.37%
Operating Profit
54.36%
EBITDA
56.02%
Net Profit/Loss for the Period
64.43%
Total Assets
-74.02%
Total Equity
N/A
Operating Profit Margin
22.08%
Net Profit Margin
30.35%
Return on Equity (ROE)
N/A
Quick Ratio
-0.39%
Cash Ratio
-0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?